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Abstract
Replication factor C (RF-C) is a heteropentameric protein essential for DNA replication and repair. It is
a molecular matchmaker required for loading of proliferating cell nuclear antigen (PCNA) onto
double-stranded DNA and, thus, for PCNA-dependent DNA elongation by DNA polymerases delta and
epsilon. To elucidate the mode of RF-C binding to the PCNA clamp, modified forms of human PCNA
were used that could be 32P-labeled in vitro either at the C or the N terminus. Using a kinase protection
assay, we show that the heteropentameric calf thymus RF-C was able to protect the C-terminal region
but not the N-terminal region of human PCNA from phosphorylation, suggesting that RF-C interacts
with the PCNA face at which the C termini are located (C-side). A similar protection profile was
obtained with the recently identified PCNA binding region (residues 478-712), but not with the DNA
binding region (residues 366-477), of the human RF-C large subunit (Fotedar, R., Mossi, R., Fitzgerald,
P., Rousselle, T., Maga, G., Brickner, H., Messner, H., Khastilba, S., Hübscher, U., and Fotedar, A.,
(1996) EMBO J., 15, 4423-4433). Furthermore, we show that the RF-C 36 kDa subunit of human RF-C
could interact independently with the C-side of PCNA. The RF-C large subunit from a third species,
namely Drosophila melanogaster, interacted similarly with the modified human PCNA, indicating that
the interaction between RF-C and PCNA is conserved through eukaryotic evolution.
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Replication factor C (RF-C) is a heteropentameric pro-
tein essential for DNA replication and repair. It is a
molecular matchmaker required for loading of prolifer-
ating cell nuclear antigen (PCNA) onto double-stranded
DNA and, thus, for PCNA-dependent DNA elongation by
DNA polymerases d and e. To elucidate the mode of RF-C
binding to the PCNA clamp, modified forms of human
PCNAwere used that could be 32P-labeled in vitro either
at the C or the N terminus. Using a kinase protection
assay, we show that the heteropentameric calf thymus
RF-C was able to protect the C-terminal region but not
the N-terminal region of human PCNA from phosphoryl-
ation, suggesting that RF-C interacts with the PCNA
face at which the C termini are located (C-side). A sim-
ilar protection profile was obtained with the recently
identified PCNA binding region (residues 478–712), but
not with the DNA binding region (residues 366–477), of
the human RF-C large subunit (Fotedar, R., Mossi, R.,
Fitzgerald, P., Rousselle, T., Maga, G., Brickner, H.,
Messner, H., Khastilba, S., Hu¨bscher, U., and Fotedar, A.,
(1996) EMBO J., 15, 4423–4433). Furthermore, we show
that the RF-C 36 kDa subunit of human RF-C could
interact independently with the C-side of PCNA. The
RF-C large subunit from a third species, namely Dro-
sophila melanogaster, interacted similarly with the
modified human PCNA, indicating that the interaction
between RF-C and PCNA is conserved through eukary-
otic evolution.
To perform processive, accurate, and rapid DNA synthesis,
DNA polymerases (pols)1 require the aid of a set of proteins
called DNA replication accessory proteins. The three best
known eukaryotic accessory proteins are proliferating cell nu-
clear antigen (PCNA) (1), replication factor C (RF-C) (2), and
replication protein A (3). These proteins are present in all
eukaryotic cells examined and are mandatory for the function
of replicative pols. Their tasks include the recruitment of pols
when needed, the facilitation of pol binding to the primer
terminus, an increase in pol processivity, prevention of non-
productive binding of pols to single-stranded DNA, the release
of pols after DNA synthesis, and communication between the
pols and other replication and cell cycle regulating proteins (for
a rewiew, see Ref. 4).
RF-C is essential in DNA replication since it is necessary for
loading of PCNA onto DNA and for subsequent DNA synthesis
of the leading strand by pol d (5). The gross structure of the
RF-C complex appears to be conserved through eukaryotic evo-
lution since RF-C isolated from either yeast or human is com-
posed of one large and four small subunits (Mr 5 140, 40, 38,
37, and 36 in human (6, 7) andMr 5 94.9, 39.7, 38.2, 36.2, and
39.9 in yeast (8)). RF-C 140 contains the DNA binding activity
(9) that has been further localized between amino acids (aa)
366–477 (10–12) to a region termed RF-C box I (8). The exact
roles of the small subunits (RF-C 40, RF-C 38, RF-C 37, and
RF-C 36) have not been determined; however, they share seven
conserved regions with the large subunit, termed RF-C boxes
II-VIII (8). Since the PCNA binding region within RF-C 140
(10, 13) contains the conserved RF-C boxes II-IV, all five sub-
units could be expected to bind PCNA. To date, only RF-C 40
has been shown to interact with PCNA (14).
The eukaryotic clamp loader, RF-C, appears to be structur-
ally and functionally very similar to its prokaryotic and viral
counterparts. The Escherichia coli g complex consists, in anal-
ogy to human RF-C, of five subunits (g, d, d9, x, c) that cooper-
ate to load the b clamp (the PCNA counterpart) onto the DNA
(15). In bacteriophage T4, the clamp loader consists of two
subunits (g44/62p) that cooperate to load the g45p clamp (16).
The amino acid sequence similarity between some of the sub-
units of these clamp loaders from prokaryotic, eukaryotic, and
viral systems (8, 17) suggests that their basic mechanism of
action may be similar.
While a high resolution model for the sliding clamp formed
by RF-C and PCNA is not yet available, an increasingly de-
tailed picture of events occurring at the prokaryotic replication
complex is emerging (18). It has been shown that both the g
complex and the core pol interact with the b ring (15). Prior to
b clamp assembly on DNA, b shows higher affinity to the g
complex than to the core pol, but once b has been assembled on
DNA, the core develops a stronger affinity for the ring and
outcompetes the g complex. After placing the b ring on the
DNA, the g clamp loader can dissociate from the complex and is
ready for loading other b dimers. Naktinis et al. (19) were able
to assign the b binding function to the d subunit of the g
complex. In the uncharged state, d is buried in the g complex,
preventing its binding to b, but upon ATP binding, the complex
undergoes a conformational change and thus exposing d for
interaction with b.
In view of the analogy with the g complex, we sought to shed
some light on the structure of the RF-CzPCNA clamp. Specifi-
cally, how does RF-C interact with PCNA in complex forma-
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tion? The crystal structure of PCNA shows a homotrimeric,
ring-shaped molecule with an overall negative charge but with
a central hole surrounded by positive charges through which
DNA slides (20). This structure is very similar to the three
dimensional structure of the b clamp despite the lack of signif-
icant sequence similarities (21). The C termini of the b subunit,
as well as those of PCNA, protrude from structurally homolo-
gous faces (C-side) of the ring and are likely candidates for
interactions with other proteins. The C-terminal amino acids of
the E. coli b ring have been shown to be important for the
interaction with both the clamp loader and the pol (15). Studies
by Fukuda et al. (22) suggested that RF-C binds to the C-side of
human PCNA, specifically to Asp41 and aa 254–257, although
the terminal four amino acids are dispensible. Asp41 is par-
tially exposed close to the C terminus in the yeast PCNA
structure, making the hypothesis plausible. Care, however,
must be taken when interpreting the effects of deletion muta-
tions in PCNA since it has been shown that deletion of C-
terminal residues can have adverse effects on the PCNA struc-
ture (23), and the trimeric structure of PCNA has been shown
to be necessary for the interaction with RF-C (24).
To study the interaction of RF-C with PCNA in more detail,
we used modified PCNA carrying artificial phosphorylation
sites at either their N or C termini (called nphPCNA and
cphPCNA, respectively) (5). In kinase protection assay experi-
ments (KPA) (18), nphPCNA or cphPCNA is incubated with the
protein to be assayed for interaction. If the protein binds to
PCNA close to either end, the artificial phosphorylation site is
expected to become less accessible to the kinase so that a
decrease in phosphorylation is observed. In this paper, we show
that the pentameric calf thymus RF-C complex protects the C
termini, but not the N termini, of PCNA from phosphorylation.
We therefore conclude that RF-C interacts with the C-side of
the PCNA ring. The RF-C 140 homologue of Drosophila mela-
nogaster is also able to protect the C termini but not the N
termini of PCNA, showing, besides its interaction with the
C-side of PCNA, that the molecular interaction between these
two auxiliary factors is conserved through evolution. More pre-
cisely, the interaction between PCNA and RF-C 140 is due to
the PCNA binding region, located in human RF-C 140 between
aa 478 and 712 (10), which also protects only the C-side of
the ring. RF-C 140 is not the only RF-C subunit involved in
PCNA binding as we could show that RF-C 36 also interacts
with PCNA and is able to protect modified PCNA from
phosphorylation.
EXPERIMENTAL PROCEDURES
Chemicals—Radioactive-labeled nucleotides were purchased from
Amersham Corp. All other reagents were of analytical grade and were
purchased from Merck (Darmstadt, Germany) or Fluka (Buchs,
Switzerland).
Buffers—The following buffers were used. Buffer A contained 25 mM
Tris-HCl (pH 7.5), 1 mM EDTA, 0.01% (v/v) Nonidet P-40, 1 mM DTT, 10
mM NaHSO3, 1 mM PMSF, and 1 mg/ml each pepstatin, leupeptin, and
aprotinin. Buffer B contained buffer A plus 10% (v/v) glycerol. Buffer C
contained 20 mM Tris-HCl (pH 7.5), 300 mM NaCl, 0.4 mM PMSF, and
1 mg/ml each aprotinin, pepstatin, and leupeptin. Buffer D contained 20
mM Tris-HCl (pH 7.5), 100 mM NaCl, 0.4 mM PMSF, 1 mM DTT, 1 mM
EDTA, and 0.5% Nonidet P-40. Buffer G contained 40 mM Tris-HCl (pH
7.5) and 10 mM MgCl2. Buffer H contained 40 mM Tris-HCl (pH 7.5), 30
mM imidazole-HCl, 10 mM MgCl2, 50 mM NaCl, and 0.1% Nonidet P-40.
Buffer I contained 40 mM Tris-HCl (pH 7.5), 10 mM MgCl2, and 0.2
mg/ml bovine serum albumin. Buffer L contained 10 mM Tris-HCl (pH
8.0), 200 mM NaCl, 1 mM EDTA, 10% (v/v) glycerol, 1 mM PMSF, and 1
mM DTT. KPA buffer contained 20 mM Tris-HCl (pH 7.5), 12 mM MgCl2,
200 mg/ml bovine serum albumin, and 1 mM DTT. SDS-gel loading
buffer contained 60 mM Tris-HCl (pH 6.8), 2% (w/v) SDS, 2%
(v/v) glycerol, 0.005% (w/v) bromphenol blue, and 2% (v/v)
b-mercaptoethanol.
Nucleic Acid Substrates—Poly(dA)1000–1500 and oligo(dT)12–18 were
purchased from Sigma and Pharmacia, respectively. Poly(dA)/oligo(dT)
(base ratio 10:1) was prepared as described (25). Singly primed M13
single-stranded DNA was prepared according to (26). Oligonucleotides
for modification and sequencing of the PCNA gene were from Mi-
crosynth (Balgach, Switzerland). The plasmid pT7/hPCNA carrying the
cDNA of human PCNA was kindly provided by B. Stillman (Cold Spring
Harbor Laboratory, NY). The pET19b/p36His, pET5a/40K, and pET16/
p128 expression vectors containing the cDNA of RF-C 36, RF-C 40, and
RF-C 128, respectively, of human RF-C were a gift of J. Hurwitz (New
York). The cDNAs encoding the fragments of the human RF-C 140 were
from A. Fotedar (La Jolla, CA).
Enzymes and Proteins—Restriction and modifying enzymes were
purchased from U. S. Biochemical Corp., New England Biolabs (NEB),
and Boehringer Mannheim. The catalytic subunit of cAMP-dependent
protein kinase from bovine heart muscle was from Sigma. Human
wtPCNA was produced in E. coli using the plasmid pT7/hPCNA and
purified as described previously (27). Calf thymus pol d and pentameric
RF-C were isolated as described (25, 28). The three fragments of human
RF-C 140, A, B, and A 1 B were purified according to (10). The N-
terminal phosphorylatable PCNA (nphPCNA) was produced and puri-
fied as described in Podust et al. (5). Cloning and isolation of RF-C 140
of D. melanogaster will be described elsewhere.2 Polyclonal antibodies
against PCNA were raised in chicken and affinity purified with protein
A-Sepharose. The alkaline phosphatase-conjugated anti-chicken anti-
body was from Sigma.
Replication Assays—The poly(dA)/oligo(dT) assay (RF-C-independ-
ent assay) was carried out according to (25). DNA replication on singly
primed M13 DNA (RF-C-dependent assay) was performed as described
previously (26).
Construction of PCNA with a C-terminal Phosphorylation Site—A
construct encoding PCNA with the C-terminal consensus phosphoryla-
tion sequence for cAMP-dependent protein kinase (Arg-Ala-Ser-Val-
Ala) was generated by PCR in analogy to a similar strategy on the N
terminus (5). The original pT7/hPCNA expression vector (27) was used
as a template for PCR with a 28-mer T7-promoter primer sequence and
a 49-mer lower primer (59-GCG CGG ATC CTA TGC AAC ACT TGC
TCT TCT AGA TCC TTC TTC ATC CTC G-39) designed to introduce the
phosphorylation site at the C terminus. The PCR product was digested
with NdeI and BamHI and recloned into the pT7 expression vector. The
resulting clone (called pT7/cphPCNA) was sequenced to confirm the
absence of mutations.
Purification of cphPCNA—E. coli BL21(DE3)pLysS cells trans-
formed with the pT7/cphPCNA expression construct were grown at
37 °C in 200 ml of LB medium to A600 5 0.4 and induced with 0.4 mM
isopropyl thiogalactoside. After 3 h, cells were harvested by centrifuga-
tion and lysed by freezing/thawing in 10 ml of buffer A containing 25
mM NaCl. The mix was sonicated and centrifuged for 30 min at
25,000 3 g. The supernatant was loaded onto a 4-ml Q-Sepharose
column and equilibrated in buffer B containing 100 mM NaCl. The
column was washed with the same buffer, and proteins were eluted
with a 50-ml linear gradient from 0.1 to 0.7 M NaCl in buffer B. The
fractions containing cphPCNA were pooled and loaded on a 1.5-ml
phenyl-Sepharose column equilibrated with buffer A containing 1.2 M
NaCl. The column was washed with buffer A without Nonidet P-40, and
cphPCNA was eluted with a 20-ml linear gradient from 1.2 to 0 M NaCl
in buffer A without Nonidet P-40. cphPCNA containing fractions were
pooled, brought to 50% (v/v) glycerol in buffer A and stored at 220 °C
until use.
Purification of RF-C 36—E. coli BL21(DE3) cells were transformed
with the pET19b plasmid containing RF-C 36 sequence linked to a His
tag at its N terminus. The cells were grown in 1 liter of LB medium to
A600 5 0.6, and isopropyl thiogalactoside was added to a final concen-
tration of 0.4 mM. The cells were further grown for 5 h at 37 °C,
harvested by centrifugation at 5,000 3 g for 20 min, and then lysed in
buffer C by three passages through a French press. The lysate was
centrifuged for 20 min at 18,000 3 g, and the pellet was solubilized in
10 ml of buffer C containing 6 M guanidinium-HCl. After ultracentrif-
ugation at 35,000 3 g for 40 min, the supernatant was dialyzed sequen-
tially against buffer C containing urea (8, 4, 2, and finally 0 M). Most of
the protein precipitated during the last dialysis step but could be
solubilized by resuspending it in buffer C containing 0.05% (v/v) Tween
20 and 0.01% (v/v) Nonidet P-40.
Subcloning, Expression, and Purification of the His-tagged RF-C
40—The gene encoding RF-C 40 was cut out of the original pET5a
2 L. K. Gaur, B. L. Allen, and S. H. Hardin, submitted for publication.
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vector with EcoRI and cloned into the pET28a1 vector, to gain RF-C 40
with a His tag at its N terminus. The resulting clone was sequenced to
confirm the reading frame and the presence of the His tag. RF-C 40 was
expressed and purified essentially as RF-C 36 except that buffer D was
used (instead of buffer C). Soluble protein was obtained by serial dial-
ysis against buffer D containing urea (4, 3, 2, 1.5, 1, 0.5, 0.25, and finally
0 M), 10% glycerol, and 1 mg/ml each of aprotinin, pepstatin, and
leupeptin.
Subcloning, Expression, and Purification of the His-tagged Human
RF-C 140—A linker encoding a 6-His tag was cloned into the single
BstBI restriction site at the end of the gene encoding RF-C 140 in
pET16b. This resulted in the expression of the human RF-C 140 His-
tagged at its C terminus. RF-C 140 was expressed and purified as
described above for RF-C 40.
KPA—250 ng (3 pmol) of cphPCNA were incubated with an excess of
the protein to be tested and with 3 mCi [g-32P]ATP in a 10-ml total
volume of KPA buffer. After 2 min at 37 °C, the phosphorylation reac-
tion was started by the addition of 0.75 units of cAMP-dependent
protein kinase. The reaction mix was further incubated at 37 °C. After
1, 2, 5, and 10 min, 2-ml aliquots were withdrawn, and the reactions
were stopped with 8 ml of 2% SDS. The samples were then analyzed by
electrophoresis on a 12% SDS-polyacrylamide gel. Gels were fixed in
10% trichloroacetic acid, soaked in 10% acetic acid/12% methanol,
dried, and autoradiographed. Gels with labeled products were exposed
on a special screen for PhosphorImager (Molecular Dynamics, Inc.).
After exposure, the screen was scanned into the PhosphorImager and
quantitation was performed with the Image Quant program of Molec-
ular Dynamics. To exclude false-positive results due to intrinsic ATPase
activity, samples were tested for the presence of free phosphate by thin
layer chromatography.
PCNA Pull-down Assay—80 pmol of the His-tagged proteins to be
assayed were mixed with 20 ml of Ni-NTA resin in buffer G. The mixture
was incubated by rocking for 1 h at 4 °C. After 3 min of centrifugation
at 2,000 3 g, the beads were washed 3 times with 1 ml of buffer G. Then
80 pmol of human wtPCNA were added to the beads in a 100-ml total
volume of buffer I. In order to allow binding of wtPCNA to the Ni-NTA
coupled proteins, the suspension was incubated at room temperature
for 1 h. After centrifugation as above, the resin was washed 4 times with
buffer H, and the proteins were eluted by boiling the beads in 30 ml of
SDS-gel loading buffer. The proteins were separated by electrophoresis
on a 12% SDS-polyacrylamide gel, and PCNA was detected by immu-
noblotting with polyclonal antibodies.
RESULTS
PCNA Containing an Artificial Phosphorylation Site Either
at the C Terminus or at the N Terminus Can Be Phosphorylated
in Vitro by cAMP-dependent Protein Kinase and Is Functionally
Active in DNA Synthesis—The C termini of PCNA, as well as
those of the b clamp in prokaryotes, protrude from one face of
the ring, making them candidates for interaction with other
proteins. The C termini of the b clamp in E. coli have been
shown to be involved both in the recognition of b by the g clamp
loader and in the binding of the pol (15). Considering the
structural and functional similarities of the prokaryotic and
eukaryotic pol sliding clamps, we designed experiments to test
the hypothesis that PCNA and RF-C interact in a way similar
to that of the b clamp and its clamp loader. For this purpose, we
used plasmids containing the human PCNA open reading
frame with an artificial phosphorylation site for cAMP-depend-
ent protein kinase fused either to its 39- or 59-end (5). Predict-
ably, these modified forms of PCNA (called cphPCNA and
nphPCNA, respectively) run slightly slower than unmodified
PCNA on an SDS-polyacrylamide gel due to the presence of the
phosphorylation sites (Fig. 1A, cphPCNA). Unlike the unmod-
ified PCNA, cphPCNA and nphPCNA (see Ref. 5) can be effi-
ciently phosphorylated in vitro (Fig. 1B, cphPCNA). Moreover,
these PCNA forms have full activity in replication assays on
primed single-stranded M13 DNA (RF-C-dependent assay; Fig.
1C, cphPCNA) and on poly(dA)/oligo(dT) (RF-C-independent
assay, data not shown) (see also Ref. 5).
The Calf Thymus RF-C Complex Protects the C Termini, But
Not the N Termini, of PCNA from Phosphorylation—First, we
studied with KPA the interaction of the calf thymus RF-C
complex with human PCNA. For this purpose, cphPCNA or
nphPCNA and a 2-fold molar excess of the calf thymus RF-C
complex were preincubated with [g-32P]ATP for 2 min at 37 °C
to allow interaction between the proteins. After addition of the
cAMP-dependent protein kinase, the kinetics of the phospho-
rylation reaction were assayed. If RF-C interacts with PCNA
close to either terminus, the accessibility of the respective
artificial phosphorylation sites to the kinase is expected to be
reduced. This results in a reduction of the amount of radioac-
tivity incorporated in the PCNA ring. In Fig. 2, we show that a
2-fold molar excess of RF-C inhibited phosphorylation of cph-
PCNA by approximately 50% after 10 min but did not inhibit
the phosphorylation of nphPCNA. This experiment provided
evidence that RF-C interacts with PCNA close enough to the C
FIG. 1. cphPCNA can be phosphorylated in vitro and is func-
tionally active. A, wtPCNA and cphPCNA (1.5 mg each) were loaded
onto a 12% SDS-polyacrylamide gel, electrophoresed, and stained with
Coomassie Blue. B, 0.4 mg of wtPCNA and cphPCNA each were incu-
bated with [g-32P]ATP and 0.75 units of cAMP-dependent protein ki-
nase for 10 min at 37 °C as described under “Experimental Procedures.”
The samples were electrophoresed (12% SDS-polyacrylamide gel), and
the gel was fixed in 10% acetic acid containing 12% methanol, dried,
and autoradiographed. C, modification of PCNA does not change its
functional activity in vitro. cphPCNA was first phosphorylated by in-
cubation for 10 min with cAMP-dependent protein kinase and 1 mM
ATP. DNA synthesis was then performed in an assay containing singly
primed M13DNA (RF-C-dependent assay) as described under “Experi-
mental Procedures.” Squares, wtPCNA; diamonds, cphPCNA, unphos-
phorylated; circles, cphPCNA, phosphorylated.
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termini to protect them from phosphorylation.
The PCNA Binding Region of Human RF-C 140 Is Able to
Protect PCNA from Phosphorylation, the DNA Binding Region
Is Not—Having shown that the pentameric calf thymus RF-C
complex interacts with the C-side of human PCNA, we next
wanted to investigate the role of RF-C 140 in this interaction.
Two functional regions of human RF-C 140 have recently been
identified (10), the DNA binding (fragment A) and the PCNA
binding regions (fragment B). The DNA binding activity was
localized between aa 366 and 477, where the conserved box I
(restricted to the large subunit) is situated (8). This region
shows striking similarity to the N-terminal regions of all bac-
terial DNA ligases sequenced to date (11, 29–31) and some-
what less, but still significant, similarity to the automodifica-
tion domain of eukaryotic poly(ADP-ribose) pols. The PCNA
binding region, which is adjacent to but does not overlap with
the DNA binding region, includes aa 478–712. This region of
the protein has been shown to inhibit SV40 DNA replication in
vitro, as well as RF-C-dependent loading of PCNA onto DNA
and RF-C-dependent DNA synthesis. It also showed a domi-
nant negative phenotype when expressed in mammalian cells
(10). Since the pentameric RF-C complex could protect cph-
PCNA from phosphorylation (see Fig. 2), the effect of the PCNA
binding region of RF-C 140 (fragment B) alone was investi-
gated in the same assay. Using a 6-fold molar excess of RF-C
140 fragment B, 80% less phosphorylation of cphPCNA was
observed after 10 min of incubation (Fig. 3A). The RF-C 140
fragment B, however, did not significantly protect human
PCNA containing an artificial phosphorylation site at its N
terminus (data not shown). This result further supported the
notion that RF-C binds to PCNA on the side where its C termini
are located rather than to the other face of the ring. To exclude
the possibility that the protection seen is an artifact caused by
the intrinsic ATPase activity of RF-C 140 fragment B, we
separated 2 ml of the KPA samples on polyethyleneimine-thin
layer chromatography after different incubation times at 37 °C.
In all cases tested, the amount of free [32P]phosphate produced
was negligible (data not shown). Consistent with its lack of
interaction with PCNA, a 6-fold molar excess of fragment A
produced no inhibition of phosphorylation (Fig. 3B). RF-C 140
fragment A 1 B, a fragment containing both regions A and B,
produced 60% inhibition of phosphorylation. In summary,
these results supported the hypothesis that the PCNA binding
region of RF-C 140 interacts with sites close to the C termini of
PCNA.
RF-C 140 Homologue of D. melanogaster Protects the C Ter-
mini of PCNA from Phosphorylation—Since it has been ob-
served that PCNA from distantly related species can be in-
terchanged in vitro and in vivo, we next tested RF-C 140 of
D. melanogaster. Although human and Schizosaccharomyces
FIG. 2. Pentameric calf thymus RF-C can protect the C termini of PCNA from phosphorylation. cphPCNA (A) or nphPCNA (B) were
treated with cAMP-dependent protein kinase in the absence or in the presence of a 2-fold molar excess of pentameric calf thymus RF-C as described
under “Experimental Procedures.” Time points were analyzed in a 12% SDS-polyacrylamide gel electrophoresis followed by autoradiography. The
first five lanes represent the reaction without ctRF-C and the last five lanes with ctRF-C. C and D, quantitation of autoradiographs A and B,
respectively. Squares, no ctRF-C; diamonds, ctRF-C. % of control, phosphorylation of cphPCNA alone after 10 min was taken as 100%.
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pombe PCNA are only 51% identical, the human protein can
complement a Schizosaccharomyces PCNA deletion mutation
(32). Similarly, D. melanogaster PCNA could substitute for
mammalian PCNA in SV40 in vitro replication although the
proteins are only 71% identical (33). We used the cloned RF-C
140 ofD. melanogaster fused with maltose binding protein2 and
tested the purified fusion protein in KPA. A 3-fold molar excess
of D. melanogaster RF-C 140 led to a 45% inhibition of cph-
PCNA phosphorylation by cAMP-dependent kinase (Fig. 4). A
7-fold excess of theD. melanogaster RF-C 140 did not cause any
protection of the N-terminally phosphorylatable PCNA (data
not shown), further supporting the involvement of the PCNA
region close to the C termini in the interaction with RF-C. The
DNA binding region of D. melanogaster RF-C 140 did not pro-
tect cphPCNA from phosphorylation (data not shown), consist-
ent with our results with human RF-C 140 fragment A (see
above). These results confirmed that RF-C interacts with
PCNA at the C-side, and not at the N-side, and that the large
subunit is involved in this interaction. Moreover, the molecular
interactions between PCNA and RF-C 140 have been conserved
through eukaryotic evolution.
Human RF-C 36 Interacts Independently with PCNA Close to
the C Termini, whereas RF-C 40 Is Not Able to Protect PCNA in
KPA or to Inhibit DNA Replication in Vitro—An interaction
between the four small RF-C subunits and PCNA is plausible
because all of them show sequence similarity to the PCNA
binding region (10) of RF-C 140 (Fig. 5). Of the four individual
small subunits, only RF-C 36 and RF-C 40 could be produced as
soluble single subunits. This is not surprising in view of the
work published by Uhlmann et al. (34) where the coexpression
FIG. 3. The PCNA binding domain but not the DNA binding domain of RF-C can protect cphPCNA from phosphorylation. A,
cphPCNA was incubated with a 6-fold molar excess of RF-C 140 fragment B (aa 378–712; the PCNA binding region) as described under
“Experimental Procedures.” For further details, see the legend to Fig. 2. B, incubation of cphPCNA with a 6-fold excess of RF-C 140 fragment A
(aa 366–477; the DNA binding region) and of fragment A 1 B (aa 366–712; both regions). C, quantitation of the autoradiograph. Squares, no RF-C;
diamonds, fragment A; triangles, fragment B; circles, fragment A 1 B. % of control, phosphorylation of cphPCNA alone after 10 min was taken
as 100%.
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of at least a subset of small subunits was required to get soluble
proteins. Nevertheless, we managed to solubilize RF-C 36 and
RF-C 40, and tested their ability to protect cphPCNA and
nphPCNA in the KPA. Incubation of RF-C 36 with cphPCNA
for 10 min resulted in a 60% inhibition of phosphorylation of
PCNA (Fig. 6, A and B), providing evidence that RF-C 36
interacts with PCNA at the C-side. On the other hand, no
protection was observed when RF-C 36 was incubated with
nphPCNA (data not shown). Further evidence for an interac-
tion between PCNA and RF-C 36 was obtained with RF-C-de-
pendent replication assays on singly primed M13 DNA. RF-C
36 inhibited DNA replication (Fig. 6C), most likely by interfer-
ing with the function of RF-C. These results were confirmed by
the inability of RF-C 36 to inhibit RF-C-independent DNA
synthesis (Fig. 6D). On the other hand, we were unable to show
any inhibition of DNA synthesis by RF-C 40 (both RF-C-de-
pendent and -independent) (Fig. 6, C and D) even by using very
low amounts (0.1 and 0.05 units) of pol d and PCNA (data not
shown), nor could we detect protection of either cph- or nph-
PCNA from phosphorylation in the KPA (data not shown).
However, we found weak ATP-dependent PCNA binding activ-
ity in RF-C 40 by direct pull-down assays (see below). Fig. 6, C
and D, also shows the effect of His-RF-C 140 fragment B on
DNA replication, confirming the results already obtained with
the GST-RF-C 140 fragment B (10). His-RF-C 140 fragment B
inhibited RF-C-dependent DNA synthesis by about 90% and,
therefore, appears to interfere strongly with the RF-CzPCNA
interaction. This strong interaction with PCNA was even re-
flected in RF-C-independent DNA replication where RF-C 140
fragment B, unlike the RF-C 36 and RF-C 40, caused inhibition
of nucleotide incorporation and thus likely trapping PCNA
from pol d.
A Pull-down Assay Supports the Interaction Data Obtained
with KPA and DNA Replication—To support the data obtained
with KPA and with the in vitro DNA replication experiments,
we took advantage of the fact that RF-C 140, RF-C 140 frag-
ment B, RF-C 36, and RF-C 40 are all His tagged so that they
could be bound to Ni-NTA-coupled resin, allowing detection of
PCNA binding with pull-down assays (see “Experimental Pro-
cedures”). We found that RF-C 140, RF-C 140 fragment B, and
RF-C 36 were able to bind to PCNA in the absence of ATP,
whereas RF-C 40, under the conditions used, was not (Fig. 7).
This was consistent with the results obtained in the KPA and
in the DNA replication experiments. Inclusion of 1 mM ATP did
not significantly alter the amount of PCNA pulled down by
RF-C 140, RF-C 140 fragment B or RF-C 36, but a weak PCNA
binding activity (less than 1% compared to RF-C 140, RF-C 140
fragment B, and RF-C 36) appeared with RF-C 40 (data not
shown), thereby indicating that RF-C 40 was properly folded.
DISCUSSION
Since its first isolation from human cells (2), RF-C has been
the subject of several studies aimed at revealing its structure,
function and properties. Several functions of this replication
factor have been identified, but the precise mechanisms hidden
behind its function remain a subject of speculation. It appears
that many features of RF-C action in DNA replication are
comparable with the g complex of E. coli, a prokaryotic coun-
terpart. Indeed, in spite of great evolutionary distance, se-
quences and functions are similar between these two protein
complexes. There are, however, details specific to the eukary-
otic replication machinery. A main goal of this work was to
begin characterizing the molecular interactions between RF-C
and PCNA by first determining the region within PCNA that is
bound by RF-C.
The subunits comprising the RF-C complex carry out a vari-
ety of activities. Human RF-C 40 has been shown to bind ATP
(9, 35). RF-C 37 was proposed to take part in the binding of
RF-C to the primer termini of both leading and lagging strands
(14). RF-C is a DNA- and PCNA-activated ATPase, an activity
that has been linked to the RF-C 3 subunit in yeast (36), which
corresponds to human RF-C 36. Recently, it was shown that
RF-C 140 specifically binds to PCNA, and a PCNA binding
region was located between aa 478–712 (10). This PCNA bind-
ing region contains the boxes II-IV that are conserved in all
RF-C subunits. This region also shows significant similarities
to the E. coli pol III subunits g/t (37, 38) and d9 (39) and to the
bacteriophage T4 gp44 protein (40).
In the crystal structure of PCNA, the C termini protrude
from one face of the ring (20), appearing as candidates for
interaction with other proteins, including RF-C. A modified
form of PCNA, the C termini of which could be artificially
phosphorylated with 32P, and different subunits and fragments
of RF-C have been used to screen for possible interactions. We
have shown that PCNA and calf thymus RF-C can interact in a
way that makes the C termini of PCNA less accessible to
cAMP-dependent kinase. A 2-fold molar excess of RF-C over
PCNA caused a 50% inhibition of phosphorylation. This sug-
gests that RF-C binds to PCNA close to the C termini of the
latter. In this interaction, the large subunit is certainly in-
volved. In fact, incubation of cphPCNA with the PCNA binding
region of human RF-C 140 resulted in a consistent inhibition of
FIG. 4. The large subunit of D. melanogaster RF-C can protect
the C termini of human PCNA from phosphorylation. A, cph-
PCNA was incubated as described for the previous experiments with a
3-fold excess of D. melanogaster RF-C 140. The last two lanes show
incubation of PCNA with RF-C 140 after boiling it for 2 min. B, quan-
tification of the cphPCNA phosphorylation. Squares, no D. melano-
gaster RF-C; diamonds, D. melanogaster RF-C; circles, D. melanogaster
RF-C, boiled. % of control, phosphorylation of cphPCNA alone after 10
min was taken as 100%.
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PCNA phosphorylation, while the DNA binding region, in
agreement with its inability to bind PCNA, did not have the
same effect. A high degree of protection of the C termini from
phosphorylation was also obtained with RF-C 36, suggesting
that this subunit interacts with the same region of PCNA. The
lower phosphorylation inhibition (50%) reached with the RF-C
36 compared with the 80% inhibition obtained with the RF-C
140 fragment B could be explained with a lower affinity of the
small subunit to the same site on PCNA. It is unclear why RF-C
140 fragment B and fragment A 1 B do not behave in the same
way, but a similar effect has been observed in other studies
(10). It may be that the DNA binding region exerts some neg-
ative steric effect on the PCNA binding region. The fact that
the native pentameric RF-C complex, as well as D. melano-
FIG. 5. Conserved regions II, III, and IV in the four small RF-C subunits are located in the PCNA binding region of RF-C 140. A
schematic alignement of the five RF-C subunits show that the small subunits share three conserved boxes (indicated as II, III, and IV) with the
PCNA binding region (aa 478–712) of RF-C 140. The DNA binding region (aa 366–477) of RF-C 140 contains RF-C box I (indicated as I). Thick
lines represent the amino acid sequence, whereas dotted lines mark breaks in the small subunit sequences for alignment with RF-C 140.
FIG. 6. The 36-kDa small subunit of human RF-C can protect the C termini of PCNA. A, cphPCNA was incubated with a 6-fold excess
of RF-C 36 for different time periods as described under “Experimental Procedures.” In the last two lanes, RF-C 36 was boiled for 2 min before
incubation with PCNA. B, quantitation of the autoradiograph. Squares, no RF-C; diamonds, RF-C 36; circles, RF-C 36, boiled. % of control,
phosphorylation of cphPCNA alone after 10 min was taken as 100%. C, effect of RF-C 36 and RF-C 40, as well as of the His-RF-C 140 fragment
B, on RF-C-dependent DNA synthesis. The effect of the addition of 100, 200, 500, and 1000 ng of the above mentioned proteins was tested in an
RF-C-dependent assay as described under “Experimental Procedures.” D, effect of human RF-C 36 and RF-C 40, as well as of the His-RF-C 140
fragment B, on RF-C-independent DNA synthesis. Diamonds, RF-C 40; squares, RF-C 36; circles, His-RF-C 140 fragment B.
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gaster RF-C 140 and the PCNA binding region of human RF-C
140, could not significantly protect the N termini of PCNA from
phosphorylation are evidence for an interaction of RF-C at the
C-side of the PCNA ring. The binding of D. melanogaster RF-C
140 to human PCNA gives rise to an important observation,
namely the strong conservation in the mode of interaction of
PCNA and RF-C throughout eukaryotic evolution. In fact, the
RF-C complex from Saccharomyces cerevisiae, mouse, human,
andD. melanogaster are all able to interact with human PCNA,
as expected from the high degree of sequence similarity ob-
served in the PCNA binding region.
In RF-C 140, the DNA binding region and the PCNA binding
region are adjacent (10) so that formation of a DNA/RF-C
complex could lead to a higher affinity of RF-C to PCNA and to
a subsequent formation of the DNA/PCNA/RF-C complex. RF-C
140 could bind first to DNA and PCNA and facilitate, by a
concerted action, the binding of the small subunits that alone
would have a lower affinity for the ring. Small subunits other
than RF-C 36 might also be involved in the PCNA interaction
since, as mentioned before, they show significant sequence
similarity to each other and, more importantly, with the PCNA
binding region of RF-C 140 (Fig. 5).
In summary, our results show that RF-C interacts with a
distinct face of the PCNA ring, namely with the C-side. This
interaction certainly involves the large subunit; among the
small subunits, RF-C 36 also interacts with PCNA at the C-
side. Our attempts to determine a site of interaction between
RF-C 40 were not successful. Although we could detect ATP-
dependent binding of His-RF-C 40 to PCNA, the interaction
seen was too weak to have an effect in KPA or in vitro DNA
replication assays. Indeed, preliminary experiments with the
yeast two-hybrid system failed to show an interaction between
RF-C 40 and PCNA,3 further suggesting that RF-C 40 may not
interact strongly with PCNA when removed from the RF-C
complex. If RF-C covers the C-side of PCNA (as implied by the
protection from phosphorylation of cphPCNA but not of nph-
PCNA), it seems plausible that the other ring side would be free
for interactions with other proteins, e.g. with pol d. Another
possibility would be that pol d competes for PCNA interaction
with RF-C and, thus, also binds to the C-side of the ring. That
this is the case for the prokaryotic replication complex was
shown by Naktinis et al. (15). However, addition of pol d to the
KPA did not show any difference in protection between cph-
and nphPCNA (data not shown). It is, therefore, not yet possi-
ble to speculate about the structure of the possible PCNA/RF-
C/pol d complex.
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FIG. 7. A pull-down assay supports the interaction data ob-
tained with KPA and DNA replication. The His-tagged proteins to
be tested for interaction with PCNA were bound to Ni-NTA beads: lane
1, RF-C 140 fragment B; lane 2, RF-C 36; lane 3, RF-C 40; lane 4,
human RF-C 140; lane 5, no protein. PCNA was then added to the beads
and binding to the different His-proteins detected as described under
“Experimental Procedures.” The arrow indicates the PCNA binding to
the RF-C 140 fragment B, to RF-C 36, and to RF-C 140 (lanes 1, 2, and
4, respectively).
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